Coronavirus company news summary – BioIQ launches at-home Covid-19 test with telehealth support – Syngene partners with HiMedia for distribution of ELISA kits in India

3 June 2020 (Last Updated June 3rd, 2020 09:57)

BioIQ has launched an at-home RT-PCR Covid-19 testing solution that is offered with a completely integrated telehealth support system. Offered in partnership with P23 Labs, BioIQ can connect employees, health plan members and individuals who need to undergo testing for Covid-19, under the virtual supervision of a clinician. The kit contains a saliva collection kit and virtual telehealth guidance. The test results are available in around 24 to 48 hours after the sample is received.

PathGroup has introduced a new, minimally-invasive nasal swab collection option under its wide-ranging SARS-CoV-2 (Covid-19) testing programme. The nasal swab, unlike other molecular diagnostic tests, is claimed to be more comfortable and easier to administer by healthcare providers. All the platforms used by the PathGroup’s testing received the Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA).

Syngene International has collaborated with HiMedia Laboratories for the manufacture and distribution of ELISA kits. As per the collaboration, HiMedia will produce the kits in its Mumbai facility. It will distribute the kits across India. Syngene developed anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its Bengaluru research facility. This test kit can test samples at once and provide results in three hours.

The Swedish National Veterinary Institute has announced that Hydrocyn aqua disinfectant has shown effectiveness against the Covid-19-causing SARS-CoV-2 virus. As per the tests carried out by the institute, it inactivated 99% of the virus particles. Inactive virus particles are not capable of infecting and are not functional. Hydrocyn was launched in March by Bactiguard.